Cipla

Cipla Limited: A Global Pharmaceutical Giant Cipla Limited, headquartered in Mumbai, stands as a prominent multinational pharmaceutical company with a global reach. Its core focus lies in developing and manufacturing medications targeting a wide spectrum of diseases, including respiratory ailments, ...

Image Source : Wikipedia

Company type Public
Industry Pharmaceuticals
Founded 1935 (90 years ago) (1935)
Founders Khwaja Abdul Hamied
Headquarters Mumbai, Maharashtra, India
Area served Worldwide
Revenue ₹25,455 crore (US$2.9 billion) (FY24)
Net income ₹4,106 crore (US$470 million) (FY24)
Number of employees 22,036
Subsidiaries Invagen Pharmaceuticals
Website www.cipla.com

Related Other Pages:

Biocon and

Sun Pharmaceuticals

Cipla history

Last Updated : 25/03/25, 11:12 PM

Cipla: A Legacy of Pharmaceutical Innovation Established in Mumbai in 1935 as Chemical, Industrial & Pharmaceutical Laboratories, Cipla, under the stewardship of Khwaja Abdul Hamied, laid the foundation for its enduring legacy. Following Hamied's death in 1972, his son Yusuf Hamied, a Cambridge-...

News

CIPLA NEWS

Maharashtra: FIR against unidentified persons posing as Cipla representatives

May 14, 2021 12:44 am

The pharmaceutical company alleged the accused were putting up posts on various social media platforms to lure people in need of the much-sought-after drugs.

Remdesivir supply, Karnataka Remdesivir, Karnataka issues notices to Cipla, Karnataka covid cases, Karnataka news, bengaluru news, Indian express

Karnataka issues notices to Cipla, Jubilant pharma companies for 'failing to supply' Remdesivir

May 12, 2021 10:10 am

The companies have failed to "supply the requisite quantity as directed by the Government of India, which has severely impacted the treatment of patients requiring Remdesivir vials in the state," the notice reads.

cyber-fraudsters, Cipla pharmaceutical, mumbai police, mumbai news, indian express

Beware of fraudsters posing as Cipla representatives: Mumbai police

May 01, 2021 5:46 am

Cipla pharmaceutical company has submitted a formal complaint to the Mumbai Cyber Police in the regard.

Cipla ties up with MSD to make, distribute investigational drug molnupiravir in India

April 28, 2021 11:27 pm

The MSD is developing molnupiravir in collaboration with Ridgeback Biotherapeutics. This agreement is a part of Cipla's efforts to enhance global access to treatment for patients affected by the pandemic.

covid 19 pandemic, herd immunity, science meets policy, coronavirus research, indian express

Cipla partners Premier Medical Corporation to launch COVID-19 rapid antigen test kits in India

December 16, 2020 12:53 pm

The company said it will commence supply of rapid point-of-care nasopharyngeal swab tests from this week.

Cipla shares rally 10% after Q1 earnings

August 10, 2020 1:12 pm

Cipla stock zoomed 9.99 per cent to Rs 801.45 -- its 52-week high -- on the BSE. It rose sharply by 9.99 per cent to its one-year high of Rs 801.50 on the NSE.

coronavirus, coronavirus in india, coronavirus causes, coronavirus treatment, coronavirus symptoms, coronavirus causes in india, coronavirus infection, coronavirus infection causes, coronavirus infection treatment, coronavirus origin, coronavirus origin in india, coronavirus news

Collaborating with govt agencies to develop treatment for COVID-19: Cipla

August 05, 2020 5:00 pm

The Mumbai-based drug firm is also ramping up manufacturing of essential drugs required in the fight against the pandemic.

coronavirus india latest updates, coronavirus drug, coronavirus treatment, remdesivir, remdesivir india, cipla remdesivir, remdesivir generic version

Cipla set to undercut rivals with generic remdesivir for Covid treatment: Sources

July 09, 2020 7:21 am

Cipla India business chief executive officer and executive vice president Nikhil Chopra said in an emailed statement that the company was launching Cipremi commercially on Wednesday and aims to supply over 80,000 vials within the first month, but did not give details on pricing or dosage.

Cipla chairman: Government steps encouraging, but don’t ignore chronic ailments

March 29, 2020 2:26 pm

Amid the coronavirus pandemic, The Indian Express caught up with Cipla chairman Y K Hamied to find out how they are preparing to meet this challenge.

Cipla shares rise following Vysov anti-diabetic drug acquisition

December 17, 2019 11:56 am

The homegrown pharma major on Monday said it has acquired brand name and trademark rights for Vysov for anti-diabetic drug Vildagliptin for the Indian market from Novartis.

Cipla Overview

Cipla history

CIPLA NEWS